SEARCH

SEARCH BY CITATION

References

  • Chambers AP, Sharkey KA, Koopmans HS (2004). Cannabinoid (CB)1 receptor antagonist, AM251, causes a sustained reduction of daily food intake in the rat. Physiol Behav 82: 863869.
  • Chen RZ, Huang RRC, Shen CP, MacNeil DJ, Fong TM (2004). Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice. Brain Res 999: 227230.
  • Chen RZ, Frassetto A, Fong TM (2006). Effects of the CB1 cannabinoid receptor inverse agonist AM251 on food intake and body weight in mice lacking μ-opioid receptors. Brain Res 1108: 176178.
  • Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL (1998). Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci 63: PL113PL117.
  • Cota D, Marsicano G, Tschop M, Grubler Y, Flachskamm C, Schubert M et al. (2003). The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112: 423431.
  • Cota D, Tschop MH, Horvath TL, Levine AS (2006). Cannabinoids, opioids and eating behavior: the molecular face of hedonism? Brain Res Rev 51: 85107.
  • De Visser L, Van Den Bos R, Kuurman WW, Kas MJH, Spruijt BM (2005). Novel approach to the behavioural characterization of inbred mice: automated home cage observations. Genes, Brain and Behav 19.
  • De Visser L, Van Den Bos R, Stoker AK, Kas MJH, Spruijt BM (2007). Effects of genetic background and environmental novelty on wheel running as a rewarding behaviour in mice. Behav Brain Res 177: 290297.
  • Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z et al. (2001). Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410: 822825.
  • Fadda P, Robinson L, Fratta W, Pertwee RG, Riedel G (2004). Differential effects of THC or CBD-rich cannabis extracts on working memory in rats. Neuropharmacol 47: 11701179.
  • Gadde KM, Allison DB (2006). Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks. Circulation 114: 974984.
  • Gallate JE, McGregor IS (1999). The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacology 142: 302308.
  • Gardner A, Mallet PE (2006). Suppression of feeding, drinking and locomotion by a putative cannabinoid receptor ‘silent antagonist’. Eur J Pharmacol 530: 103106.
  • Gill EW, Paton WDM, Pertwee RG (1970). Preliminary experiments on the chemistry and pharmacology of cannabis. Nature 228: 134136.
  • Haney M, Rabkin J, Gunderson E, Foltin RW (2005). Dronabinol and marijuana in HIV + marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology 181: 170178.
  • Hart CL, Ward AS, Haney M, Comer SD, Foltin RW, Fischman MW (2002). Comparison of smoked marijuana and oral Δ9-tetrahydrocannabinol in humans. Psychopharmacology 164: 407415.
  • Higgs S, Williams CM, Kirkham TC (2003). Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after Δ9-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. Psychopharmacology 165: 370377.
  • Hildebrandt AL, Kelly-Sullivan DM, Black SC (2003). Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice. Eur J Pharmacol 462: 125132.
  • Jamshidi N, Taylor DA (2001). Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 134: 11511154.
  • Jarrett MM, Limebeer CL, Parker LA (2005). Effect of Delta9-tetrahydrocannabinol on sucrose palatability as measured by the taste reactivity test. Physiol Behav 86: 475479.
  • Jarrett MM, Scantlebury J, Parker LA (2007). Effect of Delta(9)-tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test. Physiol Behav 90: 425430.
  • Kirkham TC, Williams CM (2001). Synergistic effects of opioid and cannabinoid antagonists on food intake. Psychopharmacology 153: 267270.
  • Kirkham TC, Williams CM, Fezza F, Di Marzo V (2002). Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136: 550557.
  • Koch JE (2001). Δ9-THC stimulates food intake in Lewis rats effects on chow, high-fat and sweet high-fat diets. Pharmacol Biochem Behav 68: 539543.
  • McLaughlin PJ, Winston KM, Swezey L, Wisniecki A, Aberman J, Tardif DJ et al. (2003). The cannabinoid CB1 antagonists SR141716A and AM251 suppress food intake and food-reinforced behaviour in a variety of tasks in rats. Behav Pharmacol 14: 583588.
  • McLaughlin PJ, Winston KM, Limebeer CL, Parker LA, Makriyannis A, Salamone JD (2005). The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats. Psychopharmacology 180: 286293.
  • Merkus FWHM (1971). Cannabivarin and tetrahydrocannabivarin, two new constituents of hashish. Nature 232: 579580.
  • Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R (2006). The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 27: 73100.
  • Pertwee RG (2004). Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sciences 76: 13071324.
  • Pertwee RG, Thomas A, Stevenson LA, Ross RA, Varvel SA, Lichtman AH et al. (2007). The psychoactive plant cannabinoid, Δ9-tetrahydrocannabinol, is antagonized by Δ8- and Δ9-tetrahydrocannabivarin in mice in vivo. Br J Pharmacol 150: 586594.
  • Ravinet-Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, Maffrand JP et al. (2003). Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 284: R345R353.
  • Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C et al. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350: 240244.
  • Rowland NE, Mukherjee M, Robertson K (2001). Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacology 159: 111116.
  • Russo EB, Guy GW, Robson PJ (2007). Cannabis, Pain and Sleep: Lessons from therapeutic clinical trials of Sativex®, a cannabis-based medicine. Chemistry and Biodiversity 4: 17291743.
  • Shearman LP, Rosko KM, Fleischer R, Wang J, Xu S, Tong XS et al. (2003). Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice. Behav Pharmacol 14: 573582.
  • Simiand J, Keane M, Keane PE, Soubrie P (1998). SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 9: 179181.
  • Sofia RD, Knobloch LC (1976). Comparative effects of various naturally occurring cannabinoids on food, sucrose and water consumption by rats. Pharmacol Biochem Behav 4: 591599.
  • Silveira Filho NG, Tufik S (1981). Comparative effects between cannabidiol and diazepam on neophobia, food intake and conflict behaviour. Res Comm Psychol Psychiat Behav 6 (3): 251266.
  • Soria-Gomez E, Matias I, Rueda-Orozco PE, Cisneros M, Petrosino S, Navarro L et al. (2007). Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-fos expression in the hypothalamus. Br J Pharmacol 151: 11091116.
  • Thiebot MH, Chaperon F, Fride E, Onaivi EM (2006). Behavioural effects of endocannabinoids. In Onaivi, E.S., Suiura, T, Di MarzoV. (eds). Endocannabinoids. Taylor & Francis: Boca Raton, pp. 303347.
  • Thomas A, Stevenson LA, Wease KN, Price MR, Baillie G, Ross RA et al. (2005). Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist. Br J Pharmacol 146: 917926.
  • Thornton-Jones ZG, Vickers SP, Clifton PG (2005). The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food. Psychopharmacology 179: 452460.
  • Timpone JG, Wright DJ, Li N, Egorin MJ, Enama ME, Mayers J et al. (1997). The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. The DATRI 004 Study Group. Division of AIDS Treatment Research Initiative. AIDS Res. Hum. Retroviruses 13: 305315.
  • Verty ANA, McGregor IS, Mallet PE (2004). Consumption of high carbohydrate, high fat and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neurosci Lett 354: 217220.
  • Verty AN, McGregor IS, Mallet PE (2005). Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of Delta(9)-tetrahydrocannabinol. Neuropharmacol 49: 11011109.
  • Vickers SP, Webster LJ, Wyatt A, Dourish CT, Kennett GA (2003). Preferential effects of the cannabinoid CB1 receptor antagonist, SR141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology 167: 103111.
  • Walsh D, Kirkova J, Davis MP (2005). The efficacy and tolerability of long-term use of dronabinol in cancer-related anorexia: a case series. J Pain Symptom Manage 30: 493495.
  • Wiley JL, Burston JJ, Leggett DC, Alekseeva OO, Razdan RK, Mahadevan A et al. (2005). CB1 cannabinoid receptor-mediated modulation of food intake in mice. Br J Pharmacol 145: 293300.
  • Williams CM, Rogers PJ, Kirkham TC (1998). Hyperphagia in pre-fed rats following oral Δ9-THC. Physiol Behav 65 (2): 343346.
  • Williams CM, Kirkham TC (2002a). Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 71: 341348.
  • Williams CM, Kirkham TC (2002b). Observational analysis of feeding induced by Δ9-THC and anandamide. Physiol Behav 76: 241250.
  • Wittman G, Deli L, Kallo I, Hrabovszky E, Watanabe M, Liposits Z et al. (2007). Distribution of type 1 cannabinoid receptor (CB1)-immunoreactive axons in the mouse hypothalamus. J Comp Neurol 503: 270279.
  • Zhou D, Shearman LP (2004). Voluntary exercise augments acute effects of CB1-receptor inverse agonist on body weight loss in obese and lean mice. Pharmacol Biochem Behav 77: 117125.